Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MediTuner is a private digital health and medtech company focused on respiratory care, offering self-management systems and home diagnostic tools for asthma, COPD, and related respiratory conditions. The company was founded in 2014 by respiratory disease specialists and built its initial product under the AsthmaTuner name before rebranding to MediTuner as it expanded beyond asthma. Its platform combines a patient app, connected spirometry, clinician-facing workflow tools, and personalized treatment guidance to support remote monitoring and follow-up. MediTuner states that its solutions are clinically validated, CE-marked, and FDA cleared/approved, and the company emphasizes collaboration with Karolinska Institutet and healthcare providers. The business appears to be commercially active in Sweden and the United States, serving patients, clinicians, and partner clinics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MediTuner.